
Torfavi 800mg Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Favipiravir (800mg)
Overview Torfavi 800mg Tablet
The antiviral medication, Torfavi 800mg Tablet, treats mild to moderate COVID-19 in adults by inhibiting viral replication, thus reducing the body's viral burden. Always adhere to your physician's prescribed dosage and regimen; avoid self-administration. Common adverse effects may include elevated blood uric acid, diarrhea, neutropenia, and increased hepatic enzymes. Report any concerning side effects to your doctor. Prior to commencing treatment, disclose any pre-existing severe hepatic or renal impairment to your doctor to ensure safety. Torfavi 800mg Tablets are contraindicated in pregnant or breastfeeding women, and those suspecting pregnancy, due to potential harm to the fetus. Patients with a history of hypersensitivity to this drug, uric acid metabolic disorders, or gout should inform their physician before use.
Uses of Torfavi 800mg Tablet
Managing the infection caused by the SARS-CoV-2 virus
Major Benefits of Torfavi 800mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the 800mg Torfavi tablet whole; avoid chewing, crushing, or fracturing it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Torfavi 800mg Tablet:
- Increased uric acid level in blood
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Increased liver enzymes
- Increased triglyceride level in blood
How to use Torfavi 800mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 800mg Torfavi tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Torfavi 800mg Tablet works:
The antiviral medication, Torfavi 800mg Tablet, inhibits SARS-CoV-2 replication. This action reduces the body's viral burden, limiting infection transmission and accelerating recovery.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Torfavi 800mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Using Torfavi 800mg tablets during pregnancy poses a substantial risk. Pregnant women should consult their physician; research in animals and pregnant humans indicates considerable harm to the fetus.
Breast feedingUNSAFE
Using Torfavi 800mg tablets while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates the medication may harm the nursing child.
DrivingCONSULT YOUR DOCTOR
Torfavi 800mg Tablet's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with severe kidney impairment should use Torfavi 800mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Torfavi 800mg tablets, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Torfavi 800mg Tablet :
Should you forget to take your Torfavi 800mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Torfavi 800mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrazinecarboxamide analog |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
